DINA BILISKE: Open Payments
NPI 1417509951 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,179 in 61 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $676 · 2025 $1,179
Food & beverage: $1,179
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $201 |
| AstraZeneca Pharmaceuticals LP | 8 | $163 |
| ABBVIE INC. | 9 | $154 |
| GlaxoSmithKline, LLC. | 8 | $148 |
| Janssen Pharmaceuticals, Inc | 4 | $71 |
| Exact Sciences Corporation | 3 | $58 |
| Novo Nordisk Inc | 3 | $52 |
| Lilly USA, LLC | 2 | $44 |
| Medtronic, Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $36 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, PREVNAR 20, QULIPTA, NURTEC ODT, SPRAVATO, REXULTI, UBRELVY.
Industry payments across OK — which companies pay providers there.
